Kalos Management, Inc. Q Bio Med Inc. Transaction History

Kalos Management, Inc.

  • $0
  • Q3 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021
SELL
$0.61 - $0.9 $6,475 - $9,553
-10,615 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$1.68 - $2.35 $17,833 - $24,945
10,615 New
10,615 $18,000

About Q BioMed Inc.

QBIO Quotes by TradingView
  • Ticker QBIO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,249,600
  • Description
  • Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, a pre-cli...
More about QBIO
Track This Portfolio

Track Kalos Management, Inc. Portfolio

Follow Kalos Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kalos Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email